A growing number of U.S. insurers are paying for patients to have medical procedures performed more cheaply overseas. And that’s raising the profile of a few companies you’ve probably never heard of. Video: Bangkok Bypass Surgery
IN THE PAST THREE MONTHS, THE CREAKY Barron’s staff has replaced a hip, two knees and undergone various nips and tucks. Based on average prices, these cost a total of at least $100,000. But abroad, say in Singapore, the tab would have been about $50,000, including stays in a private room, airfare and a vacation for the patients and their companions. Elsewhere in Asia, medical care is even cheaper. That’s why more U.S. insurers are considering financing treatment for Americans willing to travel abroad. In fact, “medical tourism” could help rein in the health-care costs that devour 16% of America’s gross domestic product.
That possibility is raising the profile of a few publicly traded companies you’ve probably never heard of: Thailand’s Bumrungrad Hospital (ticker: BH.Thailand) and Bangkok Dusit Medical Services (BGH.Thailand), Singapore’s Parkway Holdings (PWAY.Singapore) and Raffles Medical (RFMD.Singapore), and India’s Apollo Hospitals (APHS.India). Says Prathap Reddy, the U.S.-trained cardiologist who founded Apollo in 1983 and is its chairman: “We bring excellent care at a cost benefit. If the U.S. were to cover all its people, there would be a demand/supply gap. India can step in with equivalent care at one-fifth the cost.”